Heartflow’s New Chapter & The Path To Establishing A New Standard of Care
From our early days as a startup to today, one thing has remained unchanged: our belief that we can transform coronary artery disease (CAD) from the leading cause of death to a condition that can be managed for life. Now, we’re taking a powerful step forward to advance that mission.
2025 has brought many exciting milestones for Heartflow, including celebrating 15 years of progress since our founding, but we remain focused on what’s ahead and how we can achieve our vision for patients. These have been important stepping stones on the pathway toward what’s next. As we enter this next chapter, we’re better positioned than ever to bring our technology to more patients, clinicians, and health systems worldwide.
That momentum comes at a critical time. CAD remains the most prevalent type of heart disease in the United States and accounts for an estimated 1 in 5 deaths each year1,2. It’s not well understood, often misdiagnosed, or discovered only after a heart attack or other major event, while traditional diagnostic approaches can be invasive, time-consuming, and inconclusive.
Heartflow is offering a new path forward—grounded in precision, confidence, and better outcomes. As pioneers in AI for cardiovascular care, we’ve developed clinically proven, non-invasive solutions for diagnosing and managing CAD3.
Trusted by over 1,400 leading hospitals and health systems worldwide, our technology has already supported care for over 500,000 patients. The clinical evidence supporting our approach also continues to grow, with more than 600 peer-reviewed publications validating our impact on outcomes, efficiency, and cost of care. We’re also ensuring Heartflow technology is accessible to those who need it, with recent positive coverage decisions by Medicare, Cigna, and UnitedHealthcare leading the way.
And we’re just getting started.
There are still countless patients who could benefit from better CAD detection, diagnosis, and management. With an expanded reach and exciting momentum, we’re continuing to innovate and advance our platform, which brings greater precision and confidence to cardiac care.
I couldn’t be prouder of the Heartflow team. Your grit, passion, and belief in our mission brought us to this moment and will continue to carry us forward in the years ahead.
To our partners in cardiology, radiology, and hospital leadership: we are grateful for your collaboration, trust, and commitment to patient-centered innovation. To the patients who have shared their stories with us: thank you for reminding us why this work is essential. And to both our longtime and new investors: thank you for joining us in our vision to transform CAD. I’m more confident than ever in our ability to create a lasting impact.
See CAD. Manage for life.
